Eforto Terms of Service

v2026.04.23

1. Definitions

"Eforto", "we", "us", "our" — Eforto BV, a limited-liability company organised under Belgian law, registered in the Belgian Crossroads Bank for Enterprises under number BE 1030.787.326, with its registered office at 's Herenweg 16, 1860 Meise, Vlaams Brabant, Belgium, EU, and its U.S. affiliate Eforto Health Inc., a Delaware corporation with its registered office at 530, 7th Ave, Suite 902, New York NY 10018, United States (together, "Eforto").
"Consumer Device" — the Eforto R1 Device marketed in the EU/UK for general wellness / fitness purposes only (i.e. not a medical device within the meaning of Regulation (EU) 2017/745).
"Medical Device" — the Eforto M1 Vigorimeter marketed in the United States as an FDA-listed Class II device (Listing D559361). Use is restricted to qualified healthcare professionals in accordance with its Indications for Use and Instructions for Use (IFU). The M1 is not CE-marked and is not placed on the market in the European Union or the United Kingdom.
"User", "you", "your" — any natural or legal person accessing or using the Services.
"Consumer" — a natural person acting for purposes outside their trade, business, craft or profession, within the meaning of Directive 2011/83/EU and Book I of the Belgian Code of Economic Law.
"Business User" — any User that is not a Consumer, including healthcare providers, clinics, researchers and other legal entities.

2. Acceptance & Eligibility

Age. You must be at least 18 years old (or the age of majority in your jurisdiction) to create an account or place an order. Minors may only use the Services under the supervision of a parent or legal guardian who accepts these Terms on their behalf.
Authority. If you are entering into these Terms on behalf of a legal entity, you represent that you have the authority to bind that entity.

2.1. Children's Privacy

The Services are not directed to children. We do not knowingly collect personal information from children below the applicable digital age of consent without the required consent of a holder of parental responsibility.

European Union & United Kingdom. In accordance with Article 8 of Regulation (EU) 2016/679 (GDPR) and the UK GDPR, we process personal data of children on the basis of consent only where the child is at least 16 years old, or, where a lower age has been set by the applicable Member State, the age set by that law (Belgium: 13 years, pursuant to the Belgian Act of 30 July 2018, art. 7). Below that age, processing based on consent requires the consent of a holder of parental responsibility.
United States (COPPA). The Services are not directed to children under 13. In accordance with the Children's Online Privacy Protection Act (15 U.S.C. §§ 6501–6506) and 16 CFR Part 312, we do not knowingly collect personal information from children under 13 without verifiable parental consent. If we become aware that we have inadvertently collected personal information from a child under 13 without such consent, we will delete that information as soon as reasonably practicable and, before any re-enablement of the account, obtain verifiable parental consent as required by 16 CFR § 312.5.

3. Headline Disclaimers

No emergency or life-support use. The Services are not intended to detect, monitor or treat life-threatening conditions or to be used in emergencies. Call your local emergency number if you believe you may be experiencing a medical emergency.
Consumer Device (R1). The R1 is a general wellness product. Data or insights produced by the R1 are not intended to diagnose, cure, mitigate, treat, or prevent disease and have not been evaluated by medical authorities.
Medical Device (M1). Use of the M1 is restricted to the United States and only in accordance with its Indications for Use, IFU, and all applicable federal and state regulations. The M1 is not CE-marked and is not placed on the market in the EU or the UK. Any information referencing the M1 is accessed via a geo-restricted and/or credentialed portion of our websites, intended solely for qualified U.S. healthcare professionals. Where such information is nonetheless accessed from the EU or UK, it shall not be construed as an offer, promotion or making available of a medical device on those markets within the meaning of Article 7 of Regulation (EU) 2017/745 or equivalent UK legislation. You must not export, re-sell, or use the M1 outside the United States without our written consent. The M1 provides objective grip-strength metrics only; diagnostic interpretation remains solely with the qualified healthcare professional.
Scope of "Services". For avoidance of doubt, the term "Services" in these Terms and in our Privacy Policy includes (i) the consumer-wellness R1 ecosystem (device, mobile app and data monitoring platform) and (ii) the medical device M1 ecosystem (vigorimeter, mobile app and data monitoring platform).
AI-assisted outputs. Where the Services include functionality based on artificial intelligence or machine-learning models (for example, estimation of muscle fatigability, vitality capacity or pre-frailty indicators), such outputs are probabilistic and shall not be relied upon as the sole basis for a clinical decision. Where required by Article 50 of Regulation (EU) 2024/1689 (the EU AI Act), we will clearly inform Users that they are interacting with an AI system.

4. Changes to the Services or Terms

We may modify these Terms or the Services at any time. If a change is material we will provide prior notice by email or in-app notification, at least thirty (30) days in advance for Consumers where required by applicable mandatory consumer-protection law. Continued use after the effective date constitutes acceptance, save that Consumers may terminate their contract free of charge before the effective date if they do not accept the change.

5. Accounts & Security

Provide accurate, current, and complete information when creating your account and keep it updated.
Keep your credentials confidential. You are responsible for all activities that occur under your account, except to the extent caused by our failure to implement reasonable security measures.
Notify us immediately of any unauthorised use or security breach.

6. Permitted Use & Prohibited Conduct

You must use the Services only for their intended purposes and in accordance with applicable laws. Without limitation, you must not:

Copy, modify, reverse-engineer, de-compile, or create derivative works of the Services, except to the extent permitted by law (including Articles 5 and 6 of Directive 2009/24/EC on the legal protection of computer programs);
Upload malicious code, interfere with security features, or attempt unauthorised access;
Use the Services to collect or process special categories of personal data (including health data within the meaning of Article 9(1) GDPR) without a valid legal basis under Article 9(2) GDPR and, where required, the data subject's explicit consent under Article 9(2)(a) GDPR. When you upload health data, you warrant that you have obtained such consent or have another valid legal basis and that you have provided all information required under Articles 13 and 14 GDPR;
Misrepresent device capabilities or publish misleading claims about test results;
Research & Publication. Use the Services for research purposes or publish, present, or otherwise disclose results derived from the Services, without obtaining our prior written consent and complying with any guidance we provide regarding study design, branding, data protection, and — for any clinical investigation — Regulation (EU) 536/2014 (Clinical Trials Regulation), Regulation (EU) 2017/745 (MDR) as applicable, and 21 CFR Parts 50, 54, 56 and 812 in the United States.
Use the Consumer Device or app in any clinical investigation or publication without prior written approval;
Export Control & Sanctions. Use, export, re-export, or transfer the Services in violation of applicable export laws, trade embargoes, or sanctions regulations of the United States, the European Union, the United Kingdom, or other relevant jurisdictions;
High-Risk Activity Exclusion. Use the Services in connection with nuclear facilities, life-support systems, air-traffic control, or other inherently dangerous applications where failure could lead to death, personal injury, or severe property damage.

7. Intellectual-Property Rights

All content, software, trademarks, and other intellectual-property rights in the Services are owned by or licensed to Eforto and are protected by applicable laws. Except for the limited licence explicitly granted herein, no rights are transferred.

8. Licence

Subject to your compliance with these Terms, Eforto grants you a personal, non-exclusive, non-transferable, revocable, and limited licence to use the software and content made available through the Services for their intended purpose.

9. Feedback & User Submissions

If you submit comments, suggestions, or other content regarding the Services (collectively, "Feedback"), you grant Eforto a perpetual, irrevocable, worldwide, royalty-free licence to use, reproduce, modify, publish, translate, distribute, and display such Feedback for any purpose without restriction or compensation. For the avoidance of doubt, "Feedback" does not include personal data, patient-identifiable information, or Protected Health Information (as defined under HIPAA); any such data remains subject to our Privacy Policy, applicable data-protection law, and, where relevant, the Business Associate Agreement.

10. Third-Party Services & Links

The Services may contain links to third-party websites or integrate third-party tools. We are not responsible for such websites, their content, or any third-party terms.

10.1. App-Store Platform Terms

When you download the mobile app from the Apple App Store or Google Play (each a "Platform Provider"): (i) the licence granted herein is limited to a non-transferable right to use the app on any device you own or control and as permitted by the Platform Provider's terms; (ii) the Platform Provider is not a party to these Terms and has no responsibility for the app or its content, maintenance, support, warranties, product claims, or intellectual-property infringement claims; (iii) the Platform Provider and its subsidiaries are third-party beneficiaries of these Terms and may enforce them against you; and (iv) you must comply with all applicable Platform Provider terms of service. You represent that you are not located in a country subject to a U.S. Government embargo or designated as a "terrorist supporting" country, and that you are not listed on any U.S. Government list of prohibited or restricted parties.

10.2. Open-Source Software

The Services may incorporate open-source components licensed under separate terms. Those open-source licences are made available on demand at compliance@eforto.com. To the extent required by the applicable open-source licence, the provisions of that licence will apply in lieu of these Terms.

11. Pricing, Orders, Shipping & Returns (Devices)

11.1. Consumer Purchasers (B2C)

Eforto is not selling to consumers

11.2. Business Purchasers (B2B) — Devices and Hardware

The following subsection applies where you are a Business User. For the purposes of these Terms, "Devices" means any and all components, parts, or materials supplied by Eforto as part of the device system, whether provided separately or as part of an integrated package.

Pricing & Taxes. All prices are displayed in the indicated currency exclusive of taxes unless stated otherwise. We reserve the right to change prices or discontinue products at any time before we accept your order. You are responsible for all applicable duties, tariffs, customs fees and indirect taxes on importation. Where tariffs or duties are imposed or increased after order confirmation but before shipment, we reserve the right to pass through those amounts or to cancel the order.
Title and Risk of Loss. Title and risk of loss pass to you upon delivery to the carrier.
Delivery and Inspection. Devices are deemed delivered when they arrive at your specified delivery location. You must inspect the Devices within forty-eight (48) hours of delivery to confirm they conform to the agreed specifications and are free of visible defects. You must report discrepancies or defects in writing to Eforto within that period.
Acceptance. If you do not deliver a written notice of rejection specifying the reasons within the 48-hour inspection window, the Devices will be deemed accepted.
Consequences of Rejection. For any properly rejected Devices, Eforto will, at its option, (i) repair or replace the non-conforming Devices at no additional cost, or (ii) issue a credit or refund. Eforto may require you to return the rejected Devices to Eforto or its designated manufacturer; you will bear the shipping costs.
Warranty Disclaimer. Except as expressly stated in § 15, in any express written warranty accompanying the product, and subject to applicable mandatory law, Eforto disclaims all express and implied warranties, including the warranties of merchantability and fitness for a particular purpose. Notwithstanding the foregoing, Eforto warrants the proper construction, workmanship, and materials of Eforto-branded Devices for two (2) years from the date of purchase. Eforto's sole obligation, and your exclusive remedy, is repair or replacement of the defective product or parts. Business Users bear the costs of return logistics and any applicable tariffs for warranty returns.
Compliance with Laws. You are solely responsible for ensuring that your use of the Devices complies with all applicable local, national, and international laws and regulations. Eforto will not be liable for any non-compliance by you.
Force Majeure. Without limiting § 18, Eforto is not liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including but not limited to acts of God, war, terrorism, pandemics, government actions, natural disasters, or supply-chain disruptions.
Indemnification by Buyer. You agree to indemnify, defend, and hold harmless Eforto from any claims, liabilities, damages, losses, and expenses (including reasonable attorneys' fees) arising out of or connected with your use, sale, or distribution of the Devices, except to the extent such claims arise from Eforto's own negligence, wilful misconduct, or breach of these Terms.
Limitation on Claims. Any claim relating to the Devices must be brought within one (1) year after the cause of action accrues, after which it is permanently barred.
Product Use and Restrictions. You are responsible for ensuring that all operators of the Devices are properly trained and that the Devices are used, handled, stored, and maintained in accordance with the IFU and good industry practice. Eforto is not responsible for problems arising from improper use, handling, storage, or maintenance.

11.3. Replacement of Lost or Broken Hardware

At our sole discretion and subject to stock availability, we may offer a goodwill replacement of lost or damaged hardware outside the scope of any statutory or commercial warranty, on payment of logistic costs, applicable tariffs, and an administrative fee. This commercial offer does not affect your statutory rights or the express warranty rights set out in § 11.1(3) or § 11.2(6).

12. Software Updates & Support

Eforto may provide automatic firmware or app updates. By using the Services you consent to the delivery and installation of such updates. In compliance with Directive (EU) 2019/770 on digital content and, once applicable, Regulation (EU) 2024/2847 (Cyber Resilience Act), we will provide security and compatibility updates for a minimum of five (5) years from the date on which the relevant hardware is last made available on the market, or such longer period as may be required by mandatory law. The expected support period for each product is published on its product page and in the IFU. Certain updates may be required to continue using the Services.
Beta / Experimental Features. We may offer optional beta or pre-release features. Such features are provided "as is," may be subject to additional terms, and may be discontinued at any time. Your use of beta features is at your own risk.

13. Data Protection & Privacy

Our collection and processing of personal data are described in the Eforto Privacy Policy, which forms part of these Terms.

Eforto BV is the data controller for personal data processed via the Services in the European Union, the United Kingdom and the European Economic Area. Eforto Health Inc. is the data controller for personal data processed via the Services in the United States and acts, where applicable, as a HIPAA Business Associate of Covered Entities. Where Eforto BV and Eforto Health Inc. jointly determine the purposes and means of processing, they act as joint controllers within the meaning of Article 26 GDPR pursuant to the joint-controller arrangement summarised in the Privacy Policy. Where we act as a processor on your behalf (e.g. enterprise customers), the Data-Processing Agreement (DPA) applies.

We retain personal data only for as long as necessary for the purposes for which it is processed. Indicative retention periods are set out in our Privacy Policy, and include: (i) HIPAA documentation for at least six (6) years pursuant to 45 CFR § 164.530(j); (ii) medical device technical documentation and post-market surveillance records for at least ten (10) years after the last unit is placed on the market, pursuant to Article 10(8) of Regulation (EU) 2017/745 for any CE-marked device; and (iii) accounting and tax records for the periods required by Belgian law. Your rights of access, rectification, erasure, restriction, portability, and objection, and your right to lodge a complaint with a supervisory authority (Belgian Data Protection Authority, drukpersstraat 35, 1000 Brussels, www.dataprotectionauthority.be), are further described in Sections 7–8 of our Privacy Policy.

In the event of a personal-data breach, Eforto will: (i) notify the competent supervisory authority without undue delay and, where feasible, within 72 hours, pursuant to Article 33 GDPR; (ii) notify affected data subjects without undue delay where the breach is likely to result in a high risk to their rights and freedoms, pursuant to Article 34 GDPR; and (iii) where HIPAA applies, notify affected individuals, and where applicable the U.S. Department of Health and Human Services and the media, in accordance with the HIPAA Breach Notification Rule (45 CFR §§ 164.400–414), without unreasonable delay and no later than sixty (60) calendar days from discovery of the breach.

14. Electronic Communications

By creating an account, purchasing a device, or otherwise using the Services you consent to receive electronic communications from us (e.g. emails, texts, in-app messages) relating to your account and the Services on the legal basis of performance of the contract (Article 6(1)(b) GDPR). We will send you marketing communications only where you have opted in, on the basis of your consent (Article 6(1)(a) GDPR) or, where applicable, our legitimate interest in communicating with existing customers about similar products (Article 6(1)(f) GDPR and art. XII.13 of the Belgian Code of Economic Law). You can opt out of marketing emails at any time by following the unsubscribe link or by contacting compliance@eforto.com.

15. Warranties & Disclaimers

Consumer Devices & Software (R1). Provided "as is" and "as available" for general wellness purposes without warranties of any kind, save that nothing in this section excludes or limits any mandatory statutory rights of Consumers, including the statutory conformity warranty under Directive (EU) 2019/771 and the right of withdrawal under Directive 2011/83/EU.
Medical Device (M1). Subject to the limited warranty and service terms supplied with the device packaging.
We do not warrant that the Services will be uninterrupted, error-free, or that data will be entirely accurate or secure.
Product-Recall & Field-Safety Notices. If Eforto or a competent authority issues a product-recall, safety-correction, or field-safety notice pertaining to any Eforto hardware or software, you agree to: (i) provide accurate and up-to-date contact information (including a valid email address to which recall notices may be sent); (ii) promptly cease use of the affected product if instructed; and (iii) follow all recall or correction instructions, including returning or updating the product as directed. Recall and field-safety notices will be communicated by email to the address on file, posted prominently on eforto.com, and — for the M1 — reported to the U.S. Food and Drug Administration as required by 21 CFR Part 806 and Part 803.
Medical Device Vigilance (M1). If you are a U.S. healthcare professional using the M1, you may report adverse events involving the device to Eforto Health Inc. at compliance@eforto.com and to the FDA via the MedWatch programme (www.fda.gov/medwatch). Eforto Health Inc. reports adverse events and corrective actions in accordance with 21 CFR Part 803 and Part 806.

16. Limitation of Liability

16.1 General cap. To the maximum extent permitted by applicable law, Eforto (and its affiliates, officers, directors, employees, agents, and suppliers) shall not be liable for any indirect, incidental, special, consequential, exemplary, or punitive damages, or for any loss of profits, revenue, data, business opportunity, anticipated savings, or goodwill, arising out of or related to these Terms or the Services, whether based on contract, tort (including negligence), statute, or any other legal theory, and even if Eforto has been advised of the possibility of such damages. Eforto's aggregate liability arising out of or in connection with these Terms shall not exceed the greater of (i) the fees paid by Customer to Eforto in the twelve (12) months preceding the event giving rise to the claim; or (ii) [INSERT AGREED AMOUNT — suggest EUR 10,000 to 50,000 depending on typical contract value].

16.2 Mandatory carve-outs. Nothing in these Terms excludes or limits Eforto's liability for:

(i) death or personal injury caused by Eforto's negligence;

(ii) fraud or fraudulent misrepresentation;

(iii) gross negligence or wilful misconduct;

(iv) non-performance of essential obligations of these Terms (other than as a result of force majeure), in accordance with Article VI.91/4, 6° of the Belgian Code of Economic Law;

(v) liability under Regulation (EU) 2024/2853 on liability for defective products, to the extent such liability cannot lawfully be limited; or

(vi) any other liability that cannot be excluded or limited under applicable mandatory law.

16.3 Business-to-business supply. Customer acknowledges and warrants that it is entering into these Terms for purposes relating to its trade, business, craft, or profession, and is acting as an "enterprise" within the meaning of Article I.1, 1° of the Belgian Code of Economic Law. The Services are supplied on a business-to-business basis only and are not offered to consumers. Legislation applicable exclusively to contracts between traders and consumers — including, without limitation, Directive 93/13/EEC on unfair terms in consumer contracts, Directive 2011/83/EU on consumer rights, Directive (EU) 2019/770 on digital content, and Directive (EU) 2019/771 on the sale of goods — does not apply to these Terms.

16.4 End-user arrangements. Where Customer makes the Services (or any output thereof) available to its own patients, research participants, employees, or other end-users, Customer remains solely responsible for ensuring that its arrangements with such end-users comply with all applicable laws, including consumer-protection, data-protection, medical-device, and clinical-investigation laws. Customer shall indemnify Eforto against any claim brought by an end-user to the extent such claim arises from Customer's failure to comply with this Section 16.4.

16.5 U.S. mandatory law. Nothing in this Section limits any liability that cannot be limited under applicable U.S. federal or state law, including California Civil Code § 1668 (prohibiting exculpatory provisions for intentional acts, fraud, violation of law, or, in certain circumstances, gross negligence). If any provision of this Section is held unenforceable under the law of a particular jurisdiction, the remainder of the Section shall remain in full force and effect.

17. Indemnification

You shall indemnify and hold harmless Eforto from any claims, damages, liabilities, and expenses (including reasonable attorneys' fees) arising out of or related to your breach of these Terms, your misuse of the Services, or your violation of any law or third-party rights, except to the extent such claims are caused by Eforto's negligence, wilful misconduct, or breach of these Terms. This Section does not apply to Consumers to the extent it would deprive them of rights under mandatory consumer-protection law.

18. Force Majeure

Eforto shall not be liable for any delay or failure in performance resulting from acts beyond its reasonable control, including but not limited to acts of God, natural disasters, epidemic or pandemic, terrorism, riots, war, civil or military authorities, fire, flood, accidents, strikes, power or Internet outages, or shortages of transportation, fuel, energy, labour, or materials. If such an event occurs, we will make reasonable efforts to notify you and to resume performance as soon as reasonably practicable.

19. Suspension & Termination

We may suspend or terminate your access to the Services (i) if you breach these Terms; (ii) for fraud or security reasons; or (iii) if required by law. Upon termination, your right to use the Services will cease immediately. You may delete your account at any time by contacting support@eforto.com.

Consequences of termination. Upon termination of these Terms for any reason: (a) you may export your personal data in a commonly used, machine-readable format, in accordance with Article 20 GDPR, for a period of thirty (30) days after termination; (b) we will erase or anonymise your personal data in accordance with our Privacy Policy and applicable retention obligations (including those referenced in § 13); (c) any accrued rights, remedies and obligations of the parties, including those in §§ 7, 9, 13, 15, 16, 17, 20, 21 and 22, shall survive; and (d) fees already paid are non-refundable except as required by mandatory consumer-protection law or expressly provided in these Terms.

20. Governing Law, Jurisdiction & ADR

These Terms and any dispute arising out of them are governed by Belgian law, excluding its conflict-of-law rules and without prejudice to mandatory rules of the law of the Consumer's habitual residence under Article 6 of Regulation (EC) 593/2008 (Rome I).

Business Users. For Business Users, the courts of Brussels (Dutch-speaking division) have exclusive jurisdiction

Consumers. If you are a Consumer domiciled in the European Union or the United Kingdom, you may bring proceedings against Eforto in the courts of your country of domicile, and Eforto may bring proceedings against you only in those courts, in accordance with Articles 17–19 of Regulation (EU) 1215/2012 (Brussels I bis) or equivalent UK rules.

EU consumers may also: (i) use the European Commission Online Dispute Resolution (ODR) platform at https://ec.europa.eu/consumers/odr; and (ii) contact Safeshops vzw/asbl, Bd. Auguste Reyers 80, 1030 Brussels (https://www.safeshops.be), an approved Belgian ADR entity.

Eforto may, however, seek injunctive or equitable relief in any competent court worldwide to protect its intellectual-property rights.

21. Region-Specific Terms

For Users domiciled in the United States, the following provisions apply in lieu of § 20 (Governing Law, Jurisdiction & ADR). In case of conflict between this Section 21 and any other Section, this Section 21 prevails for U.S.-domiciled Users.

21.1. United States — Arbitration & Class-Action Waiver

Governing law. The Federal Arbitration Act, federal arbitration law, and the laws of the State of Delaware (without regard to choice-of-law principles) govern all claims.
Binding arbitration. Any dispute, claim, or controversy arising out of or relating to the Services or these Terms shall be settled by binding arbitration administered by the American Arbitration Association (AAA) under its Consumer Arbitration Rules. The arbitration shall take place in Wilmington, Delaware, unless the arbitrator decides a remote hearing is appropriate. Judgment on the award rendered by the arbitrator may be entered in any court of competent jurisdiction.
Class-action waiver. You and Eforto agree that claims may be brought only in an individual capacity and not as a class, collective, or representative action.
Opt-out. You may opt out of arbitration within 30 days of first accepting these Terms by emailing compliance@eforto.com with "Arbitration Opt-out" in the subject line and providing your full name and address.
California Consumer Rights Information (Cal. Civ. Code § 1789.3). If you are a California resident, you may report complaints to the Complaint Assistance Unit of the Division of Consumer Services of the California Department of Consumer Affairs by contacting them in writing at 1625 North Market Blvd., Suite N 112, Sacramento, CA 95834, or by telephone at (800) 952-5210.

21.2. United States — HIPAA

Where we act as a Business Associate under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), our Business Associate Agreement (BAA) applies and forms part of these Terms. Business Users that are Covered Entities or Business Associates under HIPAA must execute our BAA before uploading Protected Health Information to the Services. Our standard BAA form is available at eforto.com/baa and on request at compliance@eforto.com.

21.3. United Kingdom

References to EU legislation shall be read as references to the corresponding UK-retained or UK-implementing legislation where applicable, including the UK GDPR, the Data Protection Act 2018, the Consumer Rights Act 2015 and the Medical Devices Regulations 2002 (as amended).

22. Miscellaneous

Anti-corruption warranty. Each party represents that it and its officers, directors, employees, and agents will comply with all applicable anti-bribery and anti-corruption laws, including the U.S. Foreign Corrupt Practices Act, the UK Bribery Act 2010, the Belgian Penal Code (art. 246–253), and the OECD Anti-Bribery Convention.
Severability. If any provision is held invalid, the remaining provisions remain in full force and, where possible, shall be reformed to the minimum extent necessary to make them enforceable.
Assignment. You may not assign your rights or obligations without our prior written consent. We may assign our rights and obligations freely, including in a merger or sale of assets.
Entire agreement. These Terms, together with any supplemental agreements and policies (Privacy Policy, DPA, BAA, Return Policy, etc.), constitute the entire agreement between you and Eforto regarding the Services.
No waiver. Failure to enforce any provision is not a waiver.
Headings. Section headings are for convenience only and have no legal effect.
Business transfer. We may transfer our rights and data assets, including personal data, in connection with a merger, acquisition, or other corporate reorganisation, subject to the safeguards in our Privacy Policy.
Survival. Sections relating to intellectual-property, feedback, warranties, limitation of liability, indemnification, governing law, dispute resolution, confidentiality, arbitration, and any other provisions which by their nature should survive termination shall survive.

23. Accessibility & Accommodation Statement

Eforto is committed to providing a website and mobile experience that is accessible to all users. We aim to meet the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA, in line with Directive (EU) 2019/882 (European Accessibility Act, as transposed in Belgium and applicable from 28 June 2025) and applicable U.S. accessibility standards. If you experience difficulty accessing any content, feature, or functionality, please email compliance@eforto.com so we can assist you.

24. Contact

Eforto BV
's Herenweg 16, 1860 Meise, Vlaams Brabant, Belgium, EU
Email: compliance@eforto.com
Tel: +32 (0)2 306 00 00

Eforto Health Inc.
530, 7th Ave, Suite 902, New York NY 10018, United States
Email: compliance@eforto.com